Showing results (1671-1680 of 2,081) with videos related to

Sort By:
Pageof 209
Veterinary Parasitology|March 5, 2025
Strategic control of gastrointestinal nematodes in equines in an extensive livestock production system in a tropical regionMariana Green de Freitas, Gabriela Habermann Dos Santos, Denys Leandro Zanini Silva, et al.
Developmental Cell|August 30, 2023
Reconstructing human brown fat developmental trajectory in vitroJyoti Rao, Yannis Djeffal, Jerome Chal, et al.
Clinical Chemistry|May 2, 2009
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancerTheo deVos, Reimo Tetzner, Fabian Model, et al.
American Journal of Hematology|April 23, 2019
Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphomaFrédérique St-Pierre, Stephen M Broski, Betsy R LaPlant, et al.
Biological Psychiatry|May 8, 2019
Postnatal Tshz3 Deletion Drives Altered Corticostriatal Function and Autism Spectrum Disorder-like BehaviorDorian Chabbert, Xavier Caubit, Pierre L Roubertoux, et al.
BMC Surgery|July 29, 2020
Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patientsMichael R Driedger, Carlos A Puig, Cornelius A Thiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphomaPeter H Wiernik, Izidore S Lossos, Joseph M Tuscano, et al.
American Journal of Medical Genetics. Part A|November 18, 2008
The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndromeMeike Rybczynski, Alexander M J Bernhardt, Uwe Rehder, et al.
Trials|June 16, 2022
Effect of hospital-at-home vs. traditional brick-and-mortar hospital care in acutely ill adults: study protocol for a pragmatic randomized controlled trialXiaoxi Yao, Margaret Paulson, Michael J Maniaci, et al.
The Oncologist|March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced CancersAnthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
Pageof 209